Organization

Huijing Wu

1 clinical trial

Clinical trial

A Phase Ib/II Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of Relapsed/Refractory Angioimmunoblastic T-cell Lymphoma

Status: Recruiting, Estimated PCD: 2024-12-01